PRDM9 and melanoma: By combining discovery with digital expression profiling, NGS identified a novel miRNA (candidate 6), which is expressed as a part of SETDB1 transcript, a histone methyltransferase, amplified in melanoma [44] and a candidate gene for melanoma susceptibility [45].